Notably, QDTS may exert its effects on DN by modulating Akt1 and JUN and regulating key signaling pathways, such as IL-17, TNF, AGE-RAGE, and PI3K-Akt. The gene discussed is IL17A; the disease is liver dysplastic nodule.